J 2020

Incidental Accumulation of Fluciclovine in Neuroendocrine Tumour in a Patient with Oncological Duplicity

BALÁŽOVÁ, Zuzana, Igor ČERNÝ and Petr VYSKOVSKY

Basic information

Original name

Incidental Accumulation of Fluciclovine in Neuroendocrine Tumour in a Patient with Oncological Duplicity

Authors

BALÁŽOVÁ, Zuzana (703 Slovakia, guarantor, belonging to the institution), Igor ČERNÝ (203 Czech Republic, belonging to the institution) and Petr VYSKOVSKY (203 Czech Republic)

Edition

CASE REPORTS IN ONCOLOGY, BASEL, KARGER, 2020, 1662-6575

Other information

Language

English

Type of outcome

Článek v odborném periodiku

Field of Study

30204 Oncology

Country of publisher

Switzerland

Confidentiality degree

není předmětem státního či obchodního tajemství

References:

RIV identification code

RIV/00216224:14110/20:00115981

Organization unit

Faculty of Medicine

DOI

UT WoS

000533875000071

Keywords in English

Fluciclovine; Incidental uptake; Neuroendocrine tumour

Tags

Tags

International impact, Reviewed
Změněno: 15/7/2020 09:07, Mgr. Tereza Miškechová

Abstract

V originále

18F-fluciclovine is a PET radiopharmaceutical used for the detection of recurrent prostate cancer in adult men after primary curative treatment with suspicion of recurrence based on elevated prostate-specific antigen level. Several incidental uptakes of 18F-fluciclovine in other tumour types have been described in the literature so far - in breast cancer, hepatocellular carcinoma, and malignant melanoma. Our case report presents a patient with oncological duplicity (prostate gland carcinoma and newly diagnosed neuroendocrine tumour) and with accumulation of fluciclovine in pathologically proved neuroendocrine tumour, later imagined also by octreotide SPECT/CT. To our knowledge, this is the first case of fluciclovine accumulated in a neuroendocrine tumour described in the literature.